Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Advantage Plus testing strips
0601060D0BRAAA0
|
Advantage Plus (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Advantan 0.1% ointment
0603020ACBBAAAA
|
Advantan | Methylprednisolone aceponate | Endocrine System | No data available |
|
Aerodiol 150micrograms/dose nasal spray
0604011G0BSAABS
|
Aerodiol | Estradiol | Endocrine System | No data available |
|
Albiglutide 30mg inj pre-filled disposable devices
0601023ASAAAAAA
|
Albiglutide | Albiglutide | Endocrine System | No data available |
|
Albiglutide 50mg inj pre-filled disposable devices
0601023ASAAABAB
|
Albiglutide | Albiglutide | Endocrine System | No data available |
|
Alendronic acid 35mg/5ml oral solution
0606020A0AAADAD
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 5mg tablets
0606020A0AAABAB
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 70mg/5ml oral solution
0606020A0AAAEAE
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 70mg/75ml oral solution unit dose
0606020A0AAAGAG
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Amaryl 1mg tablets
0601021A0BBABAB
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 2mg tablets
0601021A0BBAAAA
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 3mg tablets
0601021A0BBACAC
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 4mg tablets
0601021A0BBADAD
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amglidia 0.6mg/ml oral suspension with 1ml oral syringe
0601021H0BNAAAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 0.6mg/ml oral suspension with 5ml oral syringe
0601021H0BNABAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 1ml oral syringe
0601021H0BNACAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 5ml oral syringe
0601021H0BNADAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Andractim 2.5% gel
0604030S0BBAAAA
|
Andractim | Androstanalone | Endocrine System | No data available |
|
Androderm 5mg/24hours transdermal patches
0604020K0BNAABC
|
Androderm | Testosterone | Endocrine System | No data available |
|
Andropatch 2.5mg/24hours patches
0604020K0BEAAA8
|
Andropatch | Testosterone | Endocrine System | No data available |
|
Andropatch 5mg/24hours patches
0604020K0BEABBC
|
Andropatch | Testosterone | Endocrine System | No data available |
|
Androstanolone 2.5% gel
0604030S0AAAAAA
|
Androstanalone | Androstanalone | Endocrine System | No data available |
|
Apidra 100units/ml inj 3ml OptiClik cartridges
0601011P0BBADAB
|
Insulin Apidra | Insulin glulisine | Endocrine System | No data available |
|
Apidra 100units/ml inj 3ml pre-filled OptiSet pens
0601011P0BBACAC
|
Insulin Apidra | Insulin glulisine | Endocrine System | No data available |
|
Aredia Dry Powder 15mg inf vials
0606020P0BBABAB
|
Aredia | Pamidronate disodium | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.